Article Details
Retrieved on: 2024-04-03 19:09:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
Arbutus Biopharma Corp., in a patent dispute with Moderna, gained favor in a court case regarding definitions of claims for lipid nanoparticle delivery technology used in Moderna's COVID-19 mRNA vaccine.
Article found on: news.bloomberglaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here